2026-06-16 2026-06-16 , online online, 1,690 € zzgl. MwSt. Dr. Willi Schnorpfeil https://forum-institut.de/seminar/26102002-market-access-healthcare-management-fundamentals/referenten/26/26_10/26102002-market-access-healthcare-management-fundamentals_schnorpfeil-willi.jpg Market Access & Healthcare Management Fundamentals

Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.

Topics
  • Structuring the European landscape: key health financing models and pharmaceutical market archetypes
  • Market Access preparation: defining an integrated evidence package
  • EU HTA and the interplay with national HTA systems
  • (Pre) launch communication & Market Access in Germany


Who should attend
This training course is designed for pharmaceutical industry professionals who need a solid foundation in market access - including new market access specialists and managers as well as marketing, medical and clinical affairs teams looking to support market access activities more effectively.
Aims and objectives
Gain a solid foundation in market access at EU and national level - focused on innovative medicines.

Four industry experts will guide you through the European payer landscape: financial models, payer archetypes, and HTA implications. Germany's HTA system serves as a deep-dive example of a value-based market.

Leave with strategic and operational know-how to drive your next launch from a market access perspective.
Your benefit

  • Four industry experts with outstanding know-how in HTA, pricing, reimbursement and launch preparation guide you through the market access process
  • Learn the crucial points for successful market access and avoid common pitfalls
  • Practical case study to apply your knowledge

26102002 Seminar Market Access & Healthcare Management Fundamentals

Market Access & Healthcare Management Fundamentals

Benefits
  • Experts with outstanding know-how in HTA, pricing, reimbursement and launch preparation
  • Learn the crucial points for successful market access
  • Practical case study to apply your knowledge

Webcode 26102002

Jetzt buchen

JETZT Buchen

Referenten


Alles auf einen Blick

Termin

20 - 21/10/2026

20 - 21/10/2026

Zeitraum

Day 1: 09:00 am - 05:00 pm
Day 2: 09:00 am - 01:30 pm

Day 1: 09:00 am - 05:00 pm
Day 2: 09:00 am - 01:30 pm
Veranstaltungsort

online

online

Gebühr
Your contact

Dr. Henriette Wolf-Klein
Department Manager

+49 6221 500-680
h.wolf-klein@forum-institut.de

Details

Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.

Topics

  • Structuring the European landscape: key health financing models and pharmaceutical market archetypes
  • Market Access preparation: defining an integrated evidence package
  • EU HTA and the interplay with national HTA systems
  • (Pre) launch communication & Market Access in Germany


Who should attend
This training course is designed for pharmaceutical industry professionals who need a solid foundation in market access - including new market access specialists and managers as well as marketing, medical and clinical affairs teams looking to support market access activities more effectively.

Aims and objectives

Gain a solid foundation in market access at EU and national level - focused on innovative medicines.

Four industry experts will guide you through the European payer landscape: financial models, payer archetypes, and HTA implications. Germany's HTA system serves as a deep-dive example of a value-based market.

Leave with strategic and operational know-how to drive your next launch from a market access perspective.

Your benefit

  • Four industry experts with outstanding know-how in HTA, pricing, reimbursement and launch preparation guide you through the market access process
  • Learn the crucial points for successful market access and avoid common pitfalls
  • Practical case study to apply your knowledge

Detailed programme

Day 1: 09:00 am - 05:00 pm
Day 2: 09:00 am - 01:30 pm

09:00 Welcome and introduction


09:20

Anne Martin

Healthcare systems and the consequences for pricing & reimbursement in Europe
  • History of healthcare systems (i.e. Bismarck, Beveridge); stakeholders, financing, developments and trends
  • Structuring the European landscape: key health financing models and pharmaceutical market archetypes (cost effectiveness, comparative-effectiveness, budget-impact and hybrid systems)
  • How system logics translate into pricing and reimbursement pathways
  • (Country) specific examples of pricing and reimbursement, including price negotiations, value based pricing, contracting models (e.g. pay for performance), managed entry examples
  • International perspective: reference pricing, launching
  • Market implications: how financing models translate into pricing, reimbursement, and access decision making
[2 coffee breaks included in the morning session]

12:30 Lunch break


13:30

Dr Willi Schnorpfeil

Market Access preparation: defining an integrated evidence package
  • Clinical evidence (RCT) and Patient relevant evidence (PROs, RWE)
  • Marketing authorisation - labelling, product information
  • HEOR aspects as QALYs, only applicable in cost driven markets?

14:50 Coffee break


15:20

Victoria Unmüßig

EU HTA and the interplay with national HTA systems
  • EU HTA framework and process: scope of Joint Clinical Assessments, roles of EU and national bodies, and interaction with national HTA
  • Timelines and methodology: key procedural steps, assessment timelines, clinical domains, and methodological requirements
  • Implications for market access strategy: evidence planning, national adaptation, and remaining areas of national decision making beyond EU HTA
  • From volume to value: to what extent does EU HTA accelerate or reshape access decision making across Europe?

17:00 End of day one


09:00

Mona Glogger

Creating the Access Environment - example Germany
  • Relevant stakeholders & stakeholder management

10:15 Coffee break


10:45

Dr Willi Schnorpfeil

(Pre) launch communication
  • European level: European advisory boards, publications
  • National level - example Germany: National KOLs
  • Conflict of interests

12:00 Short break


12:15

Mona Glogger

Case Study: Project management
  • European access
  • National access
  • Regional access

13:30 End of day 2


Good to know

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

This distinguishes our events

of 5 stars of all ratings from 2025

of 5 stars on Trustpilot = good

Recommendations

Strategisches Pricing für innovative Arzneimittel

Seminar zur Pricing- & Market-Access-Strategie: Preisfindung, Markteintritt & praktischer Workshop für innovative Arznei...

01.07.2026 in
Details
Krankenhausreform in der Umsetzung - Konsequenzen für die Healthcare-Industrie

Das KHAG wurde am 6. März im Bundestag verabschiedet - Erfahren Sie, wie die Krankenhausreform (KHVVG) und neue Finanzie...

07.07.2026 in
Details

Datenanforderungen & Statistik für das Nutzendossier

Dieser Workshop macht Sie fit für die G-BA Anhörung und vermittelt statistisches Know-how zur frühen Nutzenbewertung - ...

08.07.2026 in
Details

Healthcare Management & Market Access-Lehrgang

In 2 Lehrgangstagen erhalten Sie profundes gesundheitspolitisches und gesundheitsökonomisches Know-how sowie Praxiswisse...

26. - 27.08.2026 in
Details

Preisbildung und Abrechnung von Arzneimitteln in Deutschland

Seminar zur Preisbildung, Abrechnung und Erstattung von Arzneimitteln in Deutschland.

25.06.2026 in
Details

Go forward

In-house seminars

Our programmes are also available for in-house training. Just contact us!

Details
In-house seminars
List of abbreviations pharma & healthcare

Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.

Details
Abbreviations, Glossary
We guarantee the highest quality

We are now officially certified to ISO 9001 and ISO 21001 standard.

Details
We guarantee the highest quality